Vanguard Global Advisers’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.3M Buy
76,780
+9,529
+14% +$3.07M 0.01% 526
2026
Q2
$32.5M Buy
67,251
+1,714
+3% +$455K 0.02% 499
2026
Q1
$7.18M Buy
+65,537
New +$9.33M ﹤0.01% 678

Other funds holding ALAB

Vanguard Global Advisers's ALAB Position: Q3 2026 in Review

Vanguard Global Advisers increased its Astera Labs (ALAB) stake by 14% in Q3 2026, buying an estimated $3.07M and bringing the position to 76,780 shares worth $27.3M. The position accounts for 0.01% of the portfolio, ranked #526.

Vanguard Global Advisers first reported a position in ALAB in Q1 2026 and has held it in 3 quarters since. The position peaked at $32.5M in Q2 2026. 996 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Vanguard Global Advisers held 76,780 shares of Astera Labs worth $27.3M as of Q3 2026.
  • Vanguard Global Advisers bought 9,529 Astera Labs shares in Q3 2026, an estimated $3.07M.
  • Astera Labs made up 0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #526 holding.
  • Vanguard Global Advisers first reported a position in Astera Labs in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Astera Labs position peaked at $32.5M in Q2 2026.
  • 996 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.